Name: Meet Team Norway at the 44th JPM Healthcare Conference 2026
Start: 2026-01-12T18:00:00Z
End: 2026-01-16T02:00:00Z
Location: The Westin St. Francis Hotel

Ongoing event

12 January 2026 - 15 January 2026

Location: The Westin St. Francis Hotel, San Francisco, USA

Conference

The J.P. Morgan Healthcare Conference brings over 8,000 global investors and industry leaders to San Francisco for four days of fast-paced dealmaking and partnerships. It’s a prime opportunity to meet Norway’s most promising health companies and explore collaboration, investment and scale-up opportunities. We’ll be there — come talk to us!

Norway’s health innovation ecosystem is scaling fast — driven by strengths in digital health, biotech, radiopharma, diagnostics and medtech. A strong delegation of Norwegian companies will be present at JPM 2026.

Meet the delegation

Profile

Website

Norwegian Reception – 11 January

Together with the Royal Norwegian Consulate, Norway will host a reception on Sunday 11 January — an excellent opportunity to meet investors, partners and peers ahead of the conference rush.

Participation is by registration only. Please register and we will confirm attendance as soon as possible.

Contact us

If you’re attending JPM 2026 and want to connect with Norway’s delegation, book meeting rooms, or join the reception, reach out.

Rebecca Scheel

Director, Invest in Norway, Americas

San Francisco

John Vislosky

Senior Advisor Health Tech

New York

Tone Varslot Stave

Head of national export initiative on health and life science, Innovation Norway

Organisers

INNOVATION NORWAY

Website

Important conditions

Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.

Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.

Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.